癌症研究中的金色化物Rg3:当前趋势和未来前景 - - 综述
Auwal Ibrahim Tanko1, Salman Hosawi1, Ehssan Moglad2
1Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Current medicinal chemistry
|January 16, 2025
概括
人参中的天然化合物金色化物Rg3,通过增强免疫力和抑制癌症生长,在癌症治疗中表现有前途. 它可以提高化疗的有效性,减少副作用.
科学领域:
- 在瘤学瘤学.
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症仍然是全球领先的健康挑战,治疗结果不令人满意.
- 传统化疗因严重的副作用,有限的疗效和耐药性而面临限制.
- 帕纳克斯人参中的一种化合物金色化物Rg3正在成为癌症的有前途的天然治疗剂.
研究的目的:
- 在癌症研究中审查人参化物Rg3的当前状态.
- 阐明人参化物Rg3在癌症治疗中的多方面的机制.
- 探索其在彻底改变癌症治疗策略方面的潜力.
主要方法:
- 关于人参酸的临床前和临床研究的文献综述 Rg3.3.
- 拟议机制的分析,包括免疫增强,抗扩散,抗转移,亡诱导和抗血管生成.
- 研究其在表观遗传修饰,表皮-介质细胞转换 (EMT) 和非编码RNA调节中的作用.
主要成果:
- 金色化物Rg3表现出不同的抗癌活性.
- 它显示了增强常规癌症疗法的潜力,并通过协同相互作用减轻不良影响.
- 它的机制涉及复杂的生物途径,包括免疫调节和细胞过程调节.
结论:
- 金色化物Rg3在瘤学中具有显著的治疗潜力.
- 组合方法和基于纳米的有针对性的输送系统可能会提高其临床疗效.
- 进一步的研究是有必要的,以充分利用其在癌症治疗的能力.
相关概念视频
Positive Regulator Molecules
105.7K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K


